Biosearch Technologies, a part of LGC’s Diagnostics and Genomics division, and a global leader in high-throughput genotyping; and Dynamic Devices, a leader in automated liquid handling solutions announce their strategic partnership to provide workflow solutions for the global genomics market. By combining the innovative Lynx Robotic Liquid Handler with the SNPline™, sbeadex™ Lightning and Amp-Seq workflows, this partnership aims to deliver instruments, reagents, and consumables to service laboratories, breeders, and researchers worldwide...

LGC has announced the acquisition of Lipomed AG’s reference materials business including standards with drugs of abuse and toxicology applications, and thus greatly complementing LGC’s reference standards offering. Lipomed Reference Standards is a leading manufacturer and supplier of analytical reference standards with ISO/IEC 17025 accreditations for testing and ISO 17034 accreditation for production of reference materials...

The National Measurement Laboratory (NML) at LGC has launched the Northern Cell Metrology Hub, a new centre of innovation for clinical diagnostics and medical technology, at the University of Leeds’ innovation community, Nexus. The first step in a partnership between the University of Leeds and the NML, the laboratory was launched on Friday, 31 March 2023 at a special event hosted Nexus, which features talks from Professors Julian Braybrook and Nick Plant, as well as a visit from the Mayor of West Yorkshire Tracy Brabin.

The National Measurement Laboratory (NML) at LGC is pleased to announce that it has received an award from the Biotechnology and Biological Sciences Research Council (BBSRC) to develop standards and deliver metrology training for engineering biology. Engineering biology has the potential to offer solutions to a range of societal challenges, including food, biomedicines, clean growth and the environment...

LGC Maine Standards¹ announces the release of VALIDATE® aHBs to meet the linearity and calibration verification needs of clinical laboratories running the Roche cobas®, Abbott ALINITY, and Siemens ADVIA Centaur®, platforms. VALIDATE aHBs (Order No. 801mm) offers Hepatitis B Surface IgG Antibody (aHBs) for easy, fast, efficient linearity and calibration verification. VALIDATE aHBs test kits are liquid and ready-to-use; simply dispense the solution from each dropper bottle, directly into five sample cups, and run in replicates to verify the assay’s reportable range.

LGC Clinical Diagnostics, a leading supplier and partner to global in vitro diagnostics manufacturers and clinical laboratories, announce the extension of their exclusive partnership with Stanford University Department of Obstetrics & Gynecology - Maternal Fetal Medicine Division. Under the terms of the agreement, Stanford University will continue to provide LGC with clinical guidance in recruiting and selecting rare patient donors’ blood samples whose pregnancy has been identified with a genetic abnormality...

A breakthrough in training  for the cannabis testing industry has been launched thanks to a collaboration between experts in the National Measurement Laboratory (NML), hosted at LGC, and the reference materials division at LGC Standards. The rapid expansion of the global cannabis industry has led to sharply increased demand for safety and purity testing, but analytical laboratories are reporting a severe shortage of experienced cannabis testing staff...

LGC announce the acquisition of Rapid Genomics, a provider of mid- to high-density Next-Generation Sequencing (NGS) kits and services for genotyping in the agrigenomics market. Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing (NGS). Its Flex-Seq® Ex-L technology is provided to customers through kits and genotyping services, and allows high-throughput, cost-effective DNA analysis in plant, livestock and aquaculture genetics...

LGC Maine Standards announces the release of VALIDATE® Thyroid 2 (THY2) to meet the linearity and calibration verification needs of clinical laboratories running the Beckman Coulter Unicel® DxI/Access platform. This exciting product, with the analyte Thyroglobulin (Tg), is formulated in human serum, using the CLSI EP06-A “equal delta” sample preparation method, and provides five distinct concentrations across the claimed and extended range of the Beckman Coulter Unicel® DxI/Access instrument...

LGC Maine Standards¹ announces the release of VALIDATE® Immunosuppressants (ISx) to meet the linearity and calibration verification needs of clinical laboratories running the Abbott ARCHITECT/ALINITY or Siemens Dimension platform(s). The product, which includes analytes Cyclosporine (CSA), Tacrolimus (TAC), and Sirolimus (SIRO), is formulated in human whole blood, using the CLSI EP06-A “equal delta” sample preparation method, and provides five distinct concentrations...

An international group of scientists, led by the National Measurement Laboratory for Chemical and Bio-Measurement team at LGC, has investigated quantitative reproducibility of SARS-CoV-2 analysis and how setting diagnostic cut-offs may alter the clinical sensitivity of COVID-19 testing. This analysis is vital to understanding potential discrepancies in measured viral burden used to manage the CoVid-19 pandemic....

LGC is pleased to announce that the AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit is now CE marked for in vitro diagnostic use (CE-IVD). With this change in regulatory status, the new product name is AccuPlex SARS-CoV-2, Flu A/B and RSV Molecular Controls Kit. Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2, Flu A/B and RSV Molecular Controls Kit meets extensive design control requirements....

The Government Chemist (GC), hosted at LGC, has published the results of a recent international ring trial on the determination of cannabidiol (CBD) - an uncontrolled cannabinoid- and controlled cannabinoids in consumer products such as food and cosmetics. Consumer CBD products have entered the UK market rapidly in a variety of forms, including food and cosmetics. CBD when used as an ingredient in food or cosmetic products must currently be free from controlled cannabinoids....

LGC has released ACCURUN^® SARS-CoV-2 Antigen Reference Material Kit, a new quality measurement tool to support SARS-CoV-2 antigen testing. It is formulated for use with test methods that detect the nucleocapsid (NP) protein of SARS-CoV-2 virus – the target for the majority of the SARS-CoV-2 antigen assays currently on the market...

LGC, Biosearch Technologies announce the release of a new set of ValuPanel™ Reagents to help the efforts of public health laboratories to detect SARS-CoV-2, influenza A, and influenza B. The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex ValuPanel Reagents - which are for research use only and not for use in diagnostic procedures - consists of probes and primers for multiplex RT-PCR detection and allows discrimination of SARS-CoV-2, influenza A, and influenza B from a single patient sample....

LGC has expanded its innovative portfolio of SARS-CoV-2 quality solutions with the release of AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid reference material. The product is designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics.  It serves as an ideal research tool for assay developers as well as a complete quality solution for clinical laboratories employing such tests....

LGC’s high-throughput (HTP) RT-PCR testing system for SARS-CoV-2 has been submitted to the FDA for Emergency Use Authorisation (EUA). Testing labs can now leverage LGC’s unrivalled expertise in automated sample preparation and high-throughput RT-PCR workflows in a ready-to-deploy solution. As the need for SARS-CoV-2 testing for both diagnostic and screening applications continues to grow, many organisations are looking to expand or create testing capacity...

LGC SeraCare continues to innovate its portfolio of products supporting SARS-CoV-2 diagnostics. Initially designed to target the published CDC and WHO consensus sequences, the new AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage. This expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining the safety features....

The newly launched Version 2 Verification Panel, and Reference Material Kit, offer expanded genome coverage over the products first launched in March to now include the S gene region. As testing priorities shift from molecular to serological, LGC SeraCare also plans to expand their product offering to antibody controls in continued support of public health efforts against COVID-19. LGC SeraCare’s proprietary AccuPlex technology mimics wild-type pathogenic viruses, but is safe, non-infectious, and replication deficient...

LGC has launched a Proficiency Testing (PT) service for the detection of SARS-CoV-2 (COVID 19) by nucleic acid amplification testing, one of the first global schemes for COVID-19. As increasing numbers of diagnostic methods are made available in the global fight against COVID 19, it is essential that laboratories ensure that their application of methods and subsequent results are reliable and accurate...

The UK’s National Measurement Laboratory (NML) at LGC has expanded its portfolio of reference materials to include the first ever multi-allergen reference material kit containing five common allergens (milk, egg, almond, hazelnut, walnut), traceable to the SI (International System of Units). Food allergy is a serious and growing problem, with up to 2 million people in the UK estimated to be affected....

LGC has has announced the acquisition of C/D/N Isotopes (CDN), a leading manufacturer and supplier of deuterium-labelled compounds. The acquisition follows LGC’s recent acquisition of Toronto Research Chemicals (TRC), the leading manufacturer and supplier of analytical standards, which has enjoyed a longstanding trading relationship with CDN....

LGC’s SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories, is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuPlex™ recombinant technology. The control material is being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods directed to 2019-nCoV....

The HD-X - the very latest fully automated technology platform from Quanterix for developing and performing digital immunoassays – has been unveiled at LGC’s GLP/GCP-accredited lab in Fordham, near Cambridge, UK. The HD-X builds on the success of the HD-1 analyser in conveying unprecedented levels of sensitivity, robustness, and throughput to Pharmacokinetic-Pharmacodynamic (PK-PD) bioanalytical studies....

LGC has announced the acquisition of a majority stake in Toronto Research Chemicals (“TRC”), a leading manufacturer and supplier of synthetic organic bio-chemicals which are used as reference standards, research tools and building blocks by a highly diversified global customer base across the pharmaceutical, applied and research sectors...

LGC, the international life sciences and measurement testing company, has launched an upgrade and a new look for its Dr. Ehrenstorfer™ range of products.

The Dr. Ehrenstorfer range now includes a growing number of reference standards manufactured under LGC’s ISO Guide 34 scope of accreditation, and new outer packaging and ampoules. The improved packaging, which uses cardboard with an upgraded cellophane layer to help prevent moisture uptake....

LGC, the international life sciences and measurement testing company, is pleased to announce that its world-renowned range of proficiency testing (PT) schemes is now available via its LGC Standards web shop. 

Proficiency Testing, often referred to as external quality assessment in the medical and clinical arena, is a key element in the laboratory accreditation process, providing laboratories with an independent performance assessment to enable them monitor the quality of their analytical results as stipulated in ISO/IEC 17025 and ISO 15189....

LGC Standards is delighted to announce that their agreement to distribute the National Measurement Institute of Australia (NMIA)’s reference materials (RMs) has been renewed, allowing customers continuing access to the NMIA’s expanding range of specialist RMs in four key areas: forensic drugs, sports drugs, pesticides and veterinary materials.

The NMIA is a world renowned National Measurement Institute (NMI). It has NATA accreditation for chemical reference materials production and is fully compliant with ISO Guide 34. In particular, the NMIA is a leading centre of expertise for sports drugs testing...

As regulatory pressure increases companies are saving time and money with effective extractables and leachables programmes

LGC, the international life sciences and measurement company, is successfully preventing pitfalls which can increase drug products time to market. There is increasing regulatory pressure on pharmaceutical companies to investigate the potential interaction between a dosage form and the primary closure and transfer system employed. A thorough scientifically sound extractables and leachables (E&L) programme is, therefore, an essential regulatory requirement...

LGC, the international life sciences and measurement company, today announces that it has acquired Maine Standards Company, the leading provider of calibration verification materials for clinical laboratories in the US.

The acquisition bolsters LGC’s growing portfolio of reference materials and proficiency testing (PT) schemes for the clinical market. Euan O’Sullivan, Managing Director of LGC’s Standards Division, said, “We are delighted to welcome Maine Standards Company to LGC. Our two organisations represent a highly complementary commercial and cultural fit, with a common commitment to developing products of the very highest quality for the benefit of...

LGC, the international life sciences and measurement company, today announces that it has acquired Thistle QA, provider of a comprehensive range of over 35 proficiency testing (PT) schemes to over 6,000 participants, mainly in the clinical sector. PT is also known as EQA (external quality assessment).

Thistle’s schemes cover:

• Clinical chemistry in blood, serum and urine for a range of important tests e.g. cardiac markers, serology, haematology
• Therapeutic drugs monitoring (TDM)
• Clinical microbiology
• Food microbiology and forensic analysis.

The Anti-Doping Control Laboratory at Barcelona’s Hospital del Mar Medical Research Institute (IMIM) is a world-recognized facility performing dope testing of athletes and animals for national and international sporting events, and was an early adopter of LGC Standards LoGiCal range of reference materials

LGC and Quotient Bioresearch are pleased to announce that they have reached agreement on the sale by Quotient of its Bioanalytical Sciences division to LGC

LoGiCal® reference materials from LGC Standards have enabled specialist instrument manufacturer Spark Holland in Emmen, the Netherlands, to establish an online SPE-LC/MSMS method for the analysis of synthetic cannabinoids

Unilabs AB in Eskilstuna, Sweden, is taking advantage of LGC Standards’ LoGiCal reference materials to perform clinical analyses and screen for drugs of abuse, as chemist Elin Widing explained

LGC Standards’ webshop, featuring over 30,000 products, represents the most comprehensive source of online reference materials available

Championing measurement science and quality control in the Russian analytical market.

LGC Standards has opened its first office in St Petersburg, Russia. This new office, coming only six months after a presence in China was established, demonstrates that LGC Standards continues to grow to support laboratory quality worldwide.